The Prostate Cancer Clinical Trials Consortium: UCSF Clinical Research Site Application
Abstract
BACKGROUND: The UCSF Prostate Cancer program continues to serve as a productive and creative participant in the DOD PCCTC, by virtue of 1) Integration and interaction of outstanding basic, translational, and clinical research programs, 2) Institutional commitment towards reduction of health disparities in prostate cancer 3) Extensive experience in translational clinical trials, 4) A strong pipeline of therapeutic and diagnostic modalities including PSMA PET.OBJECTIVE: The UCSF Prostate Cancer Program seeks to develop novel therapies for men with advanced prostate cancer, with concomitant focus on reducing disparities and improving quality of life. SPECIFIC AIMS: 1) To promote equity in prostate cancer outcomes and access to clinical trials; 2) To improve quality of life and support decision-making for prostate cancer patients; 3) To investigate novel immunotherapeutic approaches and their biomarkers; 4)To advance the field of targeted radioligand therapy in prostate cancer; 5) To develop novel therapeutic strategies for oligometastatic prostate cancer; 6) To improve clinical outcomes of patients with neuroendocrine prostate cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2023
- Accession Number
- AD1216095
Entities
People
- Rahul Aggarwal
Organizations
- University of California, San Francisco